Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain
CompletedPhase 2NCT01733914
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
According to traditional Chinese medical theories, a variety of acupuncture formulas can treat diseases such as pain. For example, stimulating acupoints either local or distal to the pain site has been proposed under some conditions. We hypothesize that stimulating acupoints contralateral to the pain site can successfully treat chronic shoulder pain.
Study details
- Official title
- Phase II Study of Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain
- Conditions
- Interventions
- Sponsor
- Peking University
- Collaborators
- University of Maryland
- Start date
- 2011-09
- Primary completion
- 2013-04
- Sex
- All
- Age range
- from 25 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Uni-lateral shoulder pain for 6 weeks to 2 years * VAS score ≤ 50 * 25-65 years of age * Positive Neer's or Hawkins' signs * Accept the informed consent Exclusion Criteria: * Shoulder pain of neurological origins * Shoulder pain of neck origins * Systematic arthritis * Wrist problems * Previous shoulder, arm, neck or chest fractures or surgeries * Mental diseases * Pregnancy * Inability to work for more than 3 months before treatment * Diabetes * Coagulative dysfunction * Corticosterone or physicotherapy experience on the affected shoulder in the last 6 months * Failure to accept the informed consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01733914